We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Top Buys

Rank Stock Value
1
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$6.99M
2
RELY icon
Remitly
RELY
+$4.91M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$4.83M
4
LNG icon
Cheniere Energy
LNG
+$4.74M
5
MBLY icon
Mobileye
MBLY
+$4.61M

Top Sells

Rank Stock Value
1
NUVB icon
Nuvation Bio
NUVB
+$6.32M
2
ACN icon
Accenture
ACN
+$5.44M
3
JEF icon
Jefferies Financial Group
JEF
+$3.77M
4
QRVO icon
Qorvo
QRVO
+$3.63M
5
FYBR
Frontier Communications
FYBR
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APA icon
1651
APA Corp
APA
$13.2B
– –
-13,093
Closed -$318K
APAM icon
1652
Artisan Partners
APAM
$3.02B
– –
-13,060
Closed -$567K
APLE icon
1653
Apple Hospitality REIT
APLE
$3.82B
– –
-81,968
Closed -$984K
APLS
1654
DELISTED
Apellis Pharmaceuticals
APLS
– –
-31,446
Closed -$712K
APOG icon
1655
Apogee Enterprises
APOG
$908M
– –
-15,307
Closed -$667K
AQST icon
1656
Aquestive Therapeutics
AQST
$494M
– –
-241,359
Closed -$1.35M
AR icon
1657
Antero Resources
AR
$10.7B
– –
-26,748
Closed -$898K
ARCB icon
1658
ArcBest
ARCB
$3.08B
– –
-6,353
Closed -$444K
ARCT icon
1659
Arcturus Therapeutics
ARCT
$211M
– –
-49,012
Closed -$903K
ARES icon
1660
Ares Management
ARES
$30.9B
– –
-3,564
Closed -$570K
ARM icon
1661
Arm
ARM
$302B
– –
-5,080
Closed -$719K
ASB icon
1662
Associated Banc-Corp
ASB
$5.91B
– –
-13,966
Closed -$359K
EFOR
1663
Everforth Inc
EFOR
$1.32B
– –
-19,956
Closed -$945K
ASRT
1664
DELISTED
Assertio
ASRT
– –
-25,439
Closed -$336K
ATEC icon
1665
Alphatec Holdings
ATEC
$1.44B
– –
-43,072
Closed -$626K
ATKR icon
1666
Atkore
ATKR
$3.16B
– –
-8,808
Closed -$553K
ATMU icon
1667
Atmus Filtration Technologies
ATMU
$4.18B
– –
-5,458
Closed -$246K
ATOS icon
1668
Atossa Therapeutics
ATOS
$23.5M
– –
-20,717
Closed -$269K
ATRA icon
1669
Atara Biotherapeutics
ATRA
$76.1M
– –
-26,213
Closed -$376K
AU icon
1670
AngloGold Ashanti
AU
$48.7B
– –
-15,342
Closed -$1.08M
AXGN icon
1671
Axogen
AXGN
$2.5B
– –
-62,671
Closed -$1.12M
BABA icon
1672
Alibaba
BABA
$308B
– –
-4,038
Closed -$722K
BAH icon
1673
Booz Allen Hamilton
BAH
$9.15B
– –
-5,694
Closed -$569K
BANF icon
1674
BancFirst
BANF
$3.8B
– –
-3,222
Closed -$407K
BBIO icon
1675
BridgeBio Pharma
BBIO
$16.5B
– –
-7,299
Closed -$379K
65 66
67
68 69

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.